NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy-Reference-Cited by-同舟云学术

NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy

Published:2019-08-21 Issue:10 Volume:58 Page:1410-1415
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Hansen C. R.¹²³⁴^ORCID,Friborg J.³⁵^ORCID,Jensen K.³,Samsøe E.³⁶,Johnsen L.¹,Zukauskaite R.²⁷^ORCID,Grau C.³⁸,Maare C.⁶^ORCID,Johansen J.⁷^ORCID,Primdahl H.⁸,Bratland Å.⁹,Kristensen C. A.⁵,Andersen M¹⁰,Eriksen J. G.⁸¹¹^ORCID,Overgaard J.¹¹^ORCID

Affiliation:

1. Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark;

2. Institute of Clinical Research, University of Southern Denmark, Odense, Denmark;

3. Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark;

4. Institute of Medical Physics, School of Physics, The University of Sydney, Sydney, Australia;

5. Department of Oncology, Rigshospitalet, Copenhagen, Denmark;

6. Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, Denmark;

7. Department of Oncology, Odense University Hospital, Odense, Denmark;

8. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark;

9. The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;

10. Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;

11. Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1654129

Reference25 articles.

1. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

2. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma

3. Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach

4. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer

5. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection for proton radiotherapy of grade 1–3 glioma patients;Clinical and Translational Radiation Oncology;2024-09

2. Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study;Clinical and Translational Radiation Oncology;2024-09

3. Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines;Radiotherapy and Oncology;2024-08

4. Benefit of range uncertainty reduction in robust optimisation for proton therapy of brain, head-and-neck and breast cancer patients;Physics and Imaging in Radiation Oncology;2024-07

5. Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters;Radiotherapy and Oncology;2024-01